Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms - ScienceDirect

Frontiers Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo

Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

IJMS, Free Full-Text

Frontiers Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells

Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring

In vivo CART cell imaging: Paving the way for success in CART cell therapy - ScienceDirect

Cancers, Free Full-Text

INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia - Transplantation and Cellular Therapy, Official Publication of the American

Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity - Cytotherapy

Monitoring CAR-T Cell Therapy Production Using the LUNA-FX7™ – Logos Biosystems

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors, Journal of Hematology & Oncology

Toward precision manufacturing of immunogene T-cell therapies - Cytotherapy